{"name":"L2 Bio, LLC","slug":"l2-bio-llc","ticker":"","exchange":"","domain":"","description":"L2 Bio, LLC is a biotechnology company focused on developing innovative cell therapies, particularly in the area of adipose-derived mesenchymal stem cells (MSCs). The company's lead product, L2-01, is currently in Phase 2 clinical trials, aiming to address unmet medical needs with its advanced stem cell technology.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijgJBVV95cUxOQ3VEaW1BdHp0djJoZzFHWkpZRUxycVB5aE5EYncxdVFoNVdDNEh0ODVDQlV6ZmNKNkU5dGd6WXdQUnJhR2NISHBLdEtrWklKZzk1ckFfTkRCUTJab2xGV3FnWUE2S0xMMFY2X0hLcGhNN0N1ZFZaakp6dHp5anVLdi1lbG5saDhTbFFYQ0Q0UEhXQWZ1ZVN0bG1vQ3B4al9zSXNScGlHMlY4LXdmUW8yN2JKcmNIQ2NqRTJhdFpvdE4zVzVkU2NUQXJvSlZsZ2NCYWJHeTBPdkdTQTFyN2RyRW1fSFZjNEo5Q3BETHlXYms5cG9ERDVyODd6aGZQMzMzcnpMd3hSR1ZpS2tCQ1E?oc=5","date":"2025-06-13","type":"regulatory","source":"PRWeb","summary":"L2 Bio Seeks Principal Investigators for FDA-Approved Phase 2B Clinical Trial of Adipose-Derived Stem Cell Treatment for Crohn's Disease - PRWeb","headline":"L2 Bio Seeks Principal Investigators for FDA-Approved Phase 2B Clinical Trial of Adipose-Derived Stem Cell Treatment for","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxPa3ZIUEJzV0Izbng1c0FkUHJqendtYWo1RTgyV21kUmZubVZyWEtvN0x0bkJWUkNUbUhOSl9mUmdKVjhLN3ZpREdOSTNHMF9IbEJsdExMNmMwcHNkXy1Hem1SX1o4ODAxM3dTQVU4Q2FwN2ZrTVE5TVZIa3FoWmkzamlfbVEwR1NUaXJjSkM5X05mZnZ0NVpfQ3JOTnZJUk5rM3BFSnpGZE9pd2d0aTBKTEJSNy13Sk4tT1NvU1I3STlPaWNiLUEzZWdldGxFdFBMcFJR?oc=5","date":"2025-05-13","type":"regulatory","source":"PRWeb","summary":"L2 Bio, FDA Approves Crohn's Disease Trial as a Phase 2b Utilizing Adipose-Derived Stem Cells - PRWeb","headline":"L2 Bio, FDA Approves Crohn's Disease Trial as a Phase 2b Utilizing Adipose-Derived Stem Cells","sentiment":"positive"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}